Paper·2026·Commentary
Paper·2022·Research article
The Soluble Folate Receptor in Autism Spectrum Disorder: Relation to Autism Severity and Leucovorin Treatment.
Frye RE, Lane A, Worner A, Werner BA, McCarty PJ, Scheck AC, Collins HL, Adelman SJ, Quadros EV, Rossignol DA
Journal of Personalized Medicine, 2022
In brief
Describes a second blood marker, the soluble folate receptor, and how it relates to autism severity and to leucovorin treatment.
A plain-language summary is not written yet
The foundation is writing summaries of its papers, starting with the most important ones. Until then, the citation and the link to the journal are below.
Citation
Frye RE, Lane A, Worner A, Werner BA, McCarty PJ, Scheck AC, Collins HL, Adelman SJ, Quadros EV, Rossignol DA. The Soluble Folate Receptor in Autism Spectrum Disorder: Relation to Autism Severity and Leucovorin Treatment. J Pers Med. 2022 Dec 8;12(12):2033. doi: 10.3390/jpm12122033. PMID: 36556254; PMCID: PMC9786140.
More on biomarkers
Paper·2025·Clinical trial
Mitochondrial Supplement Improves Function and Mitochondrial Activity in Autism: A Double-Blind Placebo-Controlled Cross-Over Trial
Paper·2025·Research article
De Novo Variants Predominate in Autism Spectrum Disorder
Paper·2024·Research article
Binding Folate Receptor Alpha Autoantibody Is a Biomarker for Leucovorin Treatment Response in Autism Spectrum Disorder
Asks which blood marker predicts who responds to leucovorin, and points to the binding autoantibody.